Literature DB >> 25326049

Long-term outcome of epilepsy in patients with Prader-Willi syndrome.

Alberto Verrotti1, Raffaella Cusmai, Daniela Laino, Marco Carotenuto, Maria Esposito, Raffaele Falsaperla, Lucia Margari, Renata Rizzo, Salvatore Savasta, Salvatore Grosso, Pasquale Striano, Vincenzo Belcastro, Emilio Franzoni, Paolo Curatolo, Lucio Giordano, Elena Freri, Sara Matricardi, Dario Pruna, Irene Toldo, Elisabetta Tozzi, Lucio Lobefalo, Francesca Operto, Emma Altobelli, Francesco Chiarelli, Alberto Spalice.   

Abstract

Prader-Willi syndrome is a multisystemic genetic disorder that can be associated with epilepsy. There is insufficient information concerning the clinical and electroencephalographic characteristics of epilepsy and the long-term outcome of these patients. The aim of this study is to describe seizure types, electroencephalographic patterns and long-term seizure outcome in Prader-Willi syndrome patients suffering from epilepsy. We retrospectively studied 38 patients with Prader-Willi syndrome and seizures. Results of neuroimaging studies were obtained for 35 individuals. We subdivided these patients into two groups: group A, 24 patients, without brain lesions; and group B, 11 patients, with brain abnormalities. All patients were re-evaluated after a period of at least 10 years. Twenty-one patients (55.2 %) were affected by generalized epilepsy and 17 patients (44.8 %) presented focal epilepsy. The most common seizure type was generalized tonic-clonic seizure. The mean age at seizure onset was 4.5 years (ranged from 1 month to 14 years). In the follow-up period, seizure freedom was achieved in 32 patients (84.2 %). Seizure freedom was associated with electroencephalographic normalization, while the six children presenting drug-resistant epilepsy showed persistence of electroencephalographic abnormalities. Group B patients showed a higher prevalence of drug-resistant epilepsy. Patients with Prader-Willi syndrome were frequently affected by generalized seizures. Most of the patients had a favorable evolution, although, patients with brain abnormalities presented a worse outcome, suggesting that the presence of these lesions can influence the response to antiepileptic therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25326049     DOI: 10.1007/s00415-014-7542-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype.

Authors:  Martina Vendrame; Kiran P Maski; Madhumouli Chatterjee; Arezou Heshmati; Kalpathy Krishnamoorthy; Wen-Hann Tan; Sanjeev V Kothare
Journal:  Epilepsy Behav       Date:  2010-08-21       Impact factor: 2.937

2.  Characteristics and frequency of seizure disorder in 56 patients with Prader-Willi syndrome.

Authors:  Zheng Fan; Robert Greenwood; Amy Fisher; Surekha Pendyal; Cynthia M Powell
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

3.  The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.

Authors:  M Gunay-Aygun; S Schwartz; S Heeger; M A O'Riordan; S B Cassidy
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

4.  Multi-institutional study on the correlation between chromosomal abnormalities and epilepsy.

Authors:  Tomohiro Kumada; Masatoshi Ito; Tomoko Miyajima; Tatsuya Fujii; Takehiko Okuno; Toshin Go; Haruo Hattori; Mieko Yoshioka; Kenichiro Kobayashi; Osamu Kanazawa; Jun Tohyama; Noriyuki Akasaka; Takanori Kamimura; Mutsuo Sasagawa; Hideki Amagane; Kozo Mutoh; Yuriko Yamori; Toyoko Kanda; Naoko Yoshida; Haruyo Hirota; Rieko Tanaka; Yasushi Hamada
Journal:  Brain Dev       Date:  2005-03       Impact factor: 1.961

5.  Electroclinical characteristics of seizures-comparing Prader--Willi syndrome with Angelman syndrome.

Authors:  Pen-Jung Wang; Jia-Woei Hou; Whey-Chen Sue; Wang-Tso Lee
Journal:  Brain Dev       Date:  2005-03       Impact factor: 1.961

6.  Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome.

Authors:  L Iughetti; L Bosio; A Corrias; L Gargantini; L Ragusa; C Livieri; B Predieri; P Bruzzi; G Caselli; G Grugni
Journal:  Eur J Pediatr       Date:  2007-09-02       Impact factor: 3.183

Review 7.  ILAE official report: a practical clinical definition of epilepsy.

Authors:  Robert S Fisher; Carlos Acevedo; Alexis Arzimanoglou; Alicia Bogacz; J Helen Cross; Christian E Elger; Jerome Engel; Lars Forsgren; Jacqueline A French; Mike Glynn; Dale C Hesdorffer; B I Lee; Gary W Mathern; Solomon L Moshé; Emilio Perucca; Ingrid E Scheffer; Torbjörn Tomson; Masako Watanabe; Samuel Wiebe
Journal:  Epilepsia       Date:  2014-04-14       Impact factor: 5.864

8.  Seizures in children with Down syndrome: etiology, characteristics and outcome.

Authors:  C E Stafstrom; O F Patxot; H E Gilmore; K E Wisniewski
Journal:  Dev Med Child Neurol       Date:  1991-03       Impact factor: 5.449

9.  Prader-Willi syndrome: consensus diagnostic criteria.

Authors:  V A Holm; S B Cassidy; M G Butler; J M Hanchett; L R Greenswag; B Y Whitman; F Greenberg
Journal:  Pediatrics       Date:  1993-02       Impact factor: 7.124

10.  Epilepsy in Prader-Willi syndrome: experience of a national referral centre.

Authors:  Tal Gilboa; Varda Gross-Tsur
Journal:  Dev Med Child Neurol       Date:  2013-06-10       Impact factor: 5.449

View more
  8 in total

Review 1.  Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome.

Authors:  Katherine E Manning; Anthony J Holland
Journal:  Diseases       Date:  2015-12-17

Review 2.  Basal Forebrain Cholinergic System and Orexin Neurons: Effects on Attention.

Authors:  Ines Villano; Antonietta Messina; Anna Valenzano; Fiorenzo Moscatelli; Teresa Esposito; Vincenzo Monda; Maria Esposito; Francesco Precenzano; Marco Carotenuto; Andrea Viggiano; Sergio Chieffi; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina
Journal:  Front Behav Neurosci       Date:  2017-01-31       Impact factor: 3.558

Review 3.  Pai syndrome: a review.

Authors:  Francesca Olivero; Thomas Foiadelli; Sabino Luzzi; Gian Luigi Marseglia; Salvatore Savasta
Journal:  Childs Nerv Syst       Date:  2020-07-10       Impact factor: 1.475

4.  Prader-Willi Syndrome with Angelman Syndrome in the Offspring.

Authors:  Donatella Greco; Luigi Vetri; Letizia Ragusa; Mirella Vinci; Angelo Gloria; Paola Occhipinti; Angela Antonia Costanzo; Giuseppe Quatrosi; Michele Roccella; Serafino Buono; Corrado Romano
Journal:  Medicina (Kaunas)       Date:  2021-05-08       Impact factor: 2.430

5.  Visual-spatial training efficacy in children affected by migraine without aura: a multicenter study.

Authors:  Francesco Precenzano; Maria Ruberto; Lucia Parisi; Margherita Salerno; Agata Maltese; Beatrice Gallai; Rosa Marotta; Serena Marianna Lavano; Francesco Lavano; Michele Roccella
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-27       Impact factor: 2.570

Review 6.  Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader-Willi syndrome.

Authors:  Tzong-Shi Wang; Wen-Hsin Tsai; Li-Ping Tsai; Shi-Bing Wong
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-10-31

7.  Spectrum of Neurological Symptoms in Glycosylphosphatidylinositol Biosynthesis Defects: Systematic Review.

Authors:  Justyna Paprocka; Michał Hutny; Jagoda Hofman; Agnieszka Tokarska; Magdalena Kłaniewska; Krzysztof Szczałuba; Agnieszka Stembalska; Aleksandra Jezela-Stanek; Robert Śmigiel
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

8.  Psychiatric Symptoms and Parental Stress in Children and Adolescents With Epilepsy.

Authors:  Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Federica Pippa; Chiara Padovano; Valentina Vivenzio; Chiara Scuoppo; Ilaria Pistola; Giangennaro Coppola
Journal:  Front Neurol       Date:  2021-12-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.